Brazil In Vitro Diagnostics Market - Growth, Trends, and Forecasts (2020 - 2025)

Brazil In Vitro Diagnostics Market is segmented by Test Type (Clinical Chemistry, Molecular Diagnostics, Immunodiagnostics, Hematology, and Other Test Types), Product (Instrument, Reagent, and Other Products), Usability (Disposable IVD Devices and Reusable IVD Devices), Application (Infectious Disease, Diabetes, Cancer/Oncology, Cardiology, Autoimmune Disease, Nephrology, and Other Applications), and End User (Diagnostic Laboratories, Hospitals and Clinics, and Other End Users).

Market Snapshot

Study Period:

2020-2025

Base Year:

2019

CAGR:

5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

Brazil is a country with a growing middle-class population, a stabilizing economy, increasing urban population, and a supportive government. The country is showing a major shift in the private healthcare sector, which is a supporting factor for the IVD market.

The Brazilian healthcare funding is supported by the Ministry of Health, which runs the government hospitals in the country. The rising interests of the Brazilian researchers in molecular testing technologies, prenatal screening, and point of care (POC) glucose testing are the primary factors augmenting the growth of the market studied. 

According to the National Institute of Health, the prevalence of diabetes in Brazil was around 6.3% to 13.5% in 2016. This rising prevalence of diabetes in the country is propelling the growth of the in vitro diagnostics in Brazil. Therefore, factors, such as the rising interest of the Brazilian researchers in advanced diagnostics and high prevalence of chronic diseases, are contributing to the growth of the IVD market in the country.

Scope of the Report

  • As per the scope of the report, in vitro diagnostics involve medical devices and consumables that are utilized to perform in vitro tests on various biological samples. They are used for the diagnosis of various medical conditions, such as chronic diseases. In the report, a detailed analysis of the in vitro diagnostics market is presented, with specific attention toward diabetes and thalassemia. 
  • Brazilian in vitro diagnostics market is segmented by test type (clinical chemistry, molecular diagnostics, immunodiagnostics, hematology, and other test types), product (instrument, reagent, and other products), usability (disposable IVD devices and reusable IVD devices), application (infectious disease, diabetes, cancer/oncology, cardiology, autoimmune disease, nephrology, and other applications), and end user (diagnostic laboratories, hospitals and clinics, and other end users).
By Test Type
Clinical Chemistry
Molecular Diagnostics
Immunodiagnostics
Hematology
Other Test Types
By Product
Instrument
Reagent
Other Products
By Usability
Disposable IVD Devices
Reusable IVD Devices
By Application
Infectious Disease
Diabetes
Cancer/Oncology
Cardiology
Autoimmune Disease
Nephrology
Other Applications
By End Users
Diagnostic Laboratories
Hospitals and Clinics
Other End Users

Report scope can be customized per your requirements. Click here.

Key Market Trends

Molecular Diagnostics Segment Spearheaded the Market Studied

  • Molecular diagnostic devices are used to analyze biological markers in the genome and proteome to detect pathogens or mutations. On the basis of technology used, molecular diagnostic devices can be segmented into chips and microarrays, mass spectroscopy, next-generation sequencing (NGS), polymerase chain reaction (PCR)-based methods, cytogenetic, and molecular imaging.
  • Factors, such as large outbreaks of bacterial and viral epidemics in the world, increasing demand for point-of-care diagnostics, and rapidly evolving technology, are driving the growth of the molecular diagnostics segment.
  • Molecular diagnostics and pharmacogenomics can be used to reduce the adverse effects and toxicity of pharmaceutical interventions and facilitate cost-effective therapy by avoiding unnecessary expensive drugs, optimizing doses and timing, and eliminating ineffective drugs. The field is rapidly evolving and remains attractive to academia and the industry.
  • The use of molecular diagnostic techniques in the development and subsequent administration of personalized medicine are likely to boost the market growth.

To understand key trends, Download Sample Report

Competitive Landscape

Danaher Corporation, Roche Diagnostics, Becton, Dickinson and Company, bioMérieux, and Bio-Rad Laboratories Inc. are some of the major players in the market studied. The major companies are focusing on increasing technological advancements, in order to address customer needs, like fully automated systems, which reduces manual processes and consumables and also provides fast and accurate results.

You can also purchase parts of this report. Do you want to check out a section wise price list?

Table Of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 High Prevalence of Chronic Diseases

      2. 4.2.2 Increasing Use of Point-of-care (POC) Diagnostics

    3. 4.3 Market Restraints

      1. 4.3.1 Stringent Regulations

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Test Type

      1. 5.1.1 Clinical Chemistry

      2. 5.1.2 Molecular Diagnostics

      3. 5.1.3 Immunodiagnostics

      4. 5.1.4 Hematology

      5. 5.1.5 Other Test Types

    2. 5.2 By Product

      1. 5.2.1 Instrument

      2. 5.2.2 Reagent

      3. 5.2.3 Other Products

    3. 5.3 By Usability

      1. 5.3.1 Disposable IVD Devices

      2. 5.3.2 Reusable IVD Devices

    4. 5.4 By Application

      1. 5.4.1 Infectious Disease

      2. 5.4.2 Diabetes

      3. 5.4.3 Cancer/Oncology

      4. 5.4.4 Cardiology

      5. 5.4.5 Autoimmune Disease

      6. 5.4.6 Nephrology

      7. 5.4.7 Other Applications

    5. 5.5 By End Users

      1. 5.5.1 Diagnostic Laboratories

      2. 5.5.2 Hospitals and Clinics

      3. 5.5.3 Other End Users

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 Arkray Inc.

      3. 6.1.3 Becton, Dickinson and Company

      4. 6.1.4 bioMerieux

      5. 6.1.5 Bio-Rad Laboratories Inc.

      6. 6.1.6 Danaher Corporation

      7. 6.1.7 QIAGEN

      8. 6.1.8 Roche Diagnostics

      9. 6.1.9 Siemens AG

      10. 6.1.10 Thermo Fisher Scientific

  7. *List Not Exhaustive
  8. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Related Reports